Mitochondrial Fatty Acid Oxidation Defects--remaining Challenges

Overview

Journal J Inherit Metab Dis

Publisher Wiley

Date 2008 Oct 7

PMID 18836889

Citations 55

Authors

Niels Gregersen

Brage S Andresen

Christina B Pedersen

Rikke K J Olsen

Thomas J Corydon

Peter Bross

Affiliations

Soon will be listed here.

Abstract

Mitochondrial fatty acid oxidation defects have been recognized since the early 1970s. The discovery rate has been rather constant, with 3-4 'new' disorders identified every decade and with the most recent example, ACAD9 deficiency, reported in 2007. In this presentation we will focus on three of the 'old' defects: medium-chain acyl-CoA dehydrogenase (MCAD) deficiency, riboflavin responsive multiple acyl-CoA dehydrogenation (RR-MAD) deficiency, and short-chain acyl-CoA dehydrogenase (SCAD) deficiency. These disorders have been discussed in many publications and at countless conference presentations, and many questions relating to them have been answered. However, continuing clinical and pathophysiological research has raised many further questions, and new ideas and methodologies may be required to answer these. We will discuss these challenges. For MCAD deficiency the key question is why 80% of symptomatic patients are homozygous for the prevalent ACADM gene variation c.985A > G whereas this is found in only approximately 50% of newborns with a positive screen. For RR-MAD deficiency, the challenge is to find the connection between variations in the ETFDH gene and the observed deficiency of a number of different mitochondrial dehydrogenases as well as deficiency of FAD and coenzyme Q(10). With SCAD deficiency, the challenge is to elucidate whether ACADS gene variations are disease-associated, especially when combined with other genetic/cellular/environmental factors, which may act synergistically.

Citing Articles

Identification of ETFDH gene c. 487 + 2 T > A pathogenic variant and mechanisms for polycystic kidney in neonatal onset MADD.

Zhang B, Zhang D, Sun F, Si X, Luan M, He R Orphanet J Rare Dis. 2025; 20(1):121.

PMID: 40075430 PMC: 11905708. DOI: 10.1186/s13023-025-03640-4.

Mitochondrial diseases: from molecular mechanisms to therapeutic advances.

Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X Signal Transduct Target Ther. 2025; 10(1):9.

PMID: 39788934 PMC: 11724432. DOI: 10.1038/s41392-024-02044-3.

Micronutrient Deficiency in Inherited Metabolic Disorders Requiring Diet Regimen: A Brief Critical Review.

Tummolo A, Carella R, De Giovanni D, Paterno G, Simonetti S, Tolomeo M Int J Mol Sci. 2023; 24(23).

PMID: 38069347 PMC: 10707160. DOI: 10.3390/ijms242317024.

Combined isobutyryl-CoA and multiple acyl-CoA dehydrogenase deficiency in a boy with altered riboflavin homeostasis.

Tummolo A, Leone P, Tolomeo M, Solito R, Mattiuzzo M, Lepri F JIMD Rep. 2022; 63(4):276-291.

PMID: 35822092 PMC: 9259400. DOI: 10.1002/jmd2.12292.

Subcellular Localization of Fad1p in : A Choice at Post-Transcriptional Level?.

Bruni F, Giancaspero T, Oreb M, Tolomeo M, Leone P, Boles E Life (Basel). 2021; 11(9).

PMID: 34575116 PMC: 8470081. DOI: 10.3390/life11090967.

References

Wanders R, Duran M, IJlst L, de Jager J, van Gennip A, Jakobs C . Sudden infant death and long-chain 3-hydroxyacyl-CoA dehydrogenase. Lancet. 1989; 2(8653):52-3. DOI: 10.1016/s0140-6736(89)90300-0. View

Jackson S, Kler R, Bartlett K, Briggs H, Bindoff L, Pourfarzam M . Combined enzyme defect of mitochondrial fatty acid oxidation. J Clin Invest. 1992; 90(4):1219-25. PMC: 443162. DOI: 10.1172/JCI115983. View

Christensen E, Kolvraa S, Gregersen N . Glutaric aciduria type II: evidence for a defect related to the electron transfer flavoprotein or its dehydrogenase. Pediatr Res. 1984; 18(7):663-7. DOI: 10.1203/00006450-198407000-00020. View

Andresen B, Olpin S, Poorthuis B, Scholte H, Vianey-Saban C, Wanders R . Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet. 1999; 64(2):479-94. PMC: 1377757. DOI: 10.1086/302261. View

Koeberl D, Young S, Gregersen N, Vockley J, Smith W, Benjamin Jr D . Rare disorders of metabolism with elevated butyryl- and isobutyryl-carnitine detected by tandem mass spectrometry newborn screening. Pediatr Res. 2003; 54(2):219-23. DOI: 10.1203/01.PDR.0000074972.36356.89. View

Bougneres P, Saudubray J, Marsac C, Bernard O, Odievre M, Girard J . Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr. 1981; 98(5):742-6. DOI: 10.1016/s0022-3476(81)80834-7. View

Olsen R, Olpin S, Andresen B, Miedzybrodzka Z, Pourfarzam M, Merinero B . ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain. 2007; 130(Pt 8):2045-54. DOI: 10.1093/brain/awm135. View

Vergani L, Barile M, Angelini C, Burlina A, Nijtmans L, Freda M . Riboflavin therapy. Biochemical heterogeneity in two adult lipid storage myopathies. Brain. 1999; 122 ( Pt 12):2401-11. DOI: 10.1093/brain/122.12.2401. View

Pedersen C, Bross P, Winter V, Corydon T, Bolund L, Bartlett K . Misfolding, degradation, and aggregation of variant proteins. The molecular pathogenesis of short chain acyl-CoA dehydrogenase (SCAD) deficiency. J Biol Chem. 2003; 278(48):47449-58. DOI: 10.1074/jbc.M309514200. View

10.

Kurian M, Hartley L, Zolkipli Z, Little M, Costigan D, Naughten E . Short-chain acyl-CoA dehydrogenase deficiency associated with early onset severe axonal neuropathy. Neuropediatrics. 2004; 35(5):312-6. DOI: 10.1055/s-2004-830371. View

11.

IJlst L, Wanders R, Ushikubo S, Kamijo T, Hashimoto T . Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta. 1994; 1215(3):347-50. DOI: 10.1016/0005-2760(94)90064-7. View

12.

Amendt B, Greene C, Sweetman L, Cloherty J, Shih V, Moon A . Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. J Clin Invest. 1987; 79(5):1303-9. PMC: 424368. DOI: 10.1172/JCI112953. View

13.

He M, Rutledge S, Kelly D, Palmer C, Murdoch G, Majumder N . A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency. Am J Hum Genet. 2007; 81(1):87-103. PMC: 1950923. DOI: 10.1086/519219. View

14.

Zhang J, Frerman F, Kim J . Structure of electron transfer flavoprotein-ubiquinone oxidoreductase and electron transfer to the mitochondrial ubiquinone pool. Proc Natl Acad Sci U S A. 2006; 103(44):16212-7. PMC: 1637562. DOI: 10.1073/pnas.0604567103. View

15.

Tanaka K, Yokota I, Coates P, Strauss A, Kelly D, Zhang Z . Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene. Hum Mutat. 1992; 1(4):271-9. DOI: 10.1002/humu.1380010402. View

16.

Kolvraa S, Gregersen N, Christensen E, Hobolth N . In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase. Clin Chim Acta. 1982; 126(1):53-67. DOI: 10.1016/0009-8981(82)90361-8. View

17.

Karpati G, Carpenter S, Engel A, Watters G, Allen J, Rothman S . The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology. 1975; 25(1):16-24. DOI: 10.1212/wnl.25.1.16. View

18.

Nielsen K, Sorensen S, Cartegni L, Corydon T, Doktor T, Schroeder L . Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet. 2007; 80(3):416-32. PMC: 1821120. DOI: 10.1086/511992. View

19.

Gregersen N, Wintzensen H, Christensen S, Christensen M, BRANDT N, Rasmussen K . C6-C10-dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl-CoA dehydrogenation defects. Pediatr Res. 1982; 16(10):861-8. DOI: 10.1203/00006450-198210000-00012. View

20.

Bross P, Andresen B, Winter V, Krautle F, Jensen T, Nandy A . Co-overexpression of bacterial GroESL chaperonins partly overcomes non-productive folding and tetramer assembly of E. coli-expressed human medium-chain acyl-CoA dehydrogenase (MCAD) carrying the prevalent disease-causing K304E mutation. Biochim Biophys Acta. 1993; 1182(3):264-74. DOI: 10.1016/0925-4439(93)90068-c. View